Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking;İzole anti̇-HBc pozi̇ti̇f olgularda HBV-DNA varliǧinin araştirilmasi ve bu olgularin kan bankaciliǧi açsindan önemi̇

Mikrobiyoloji Bulteni

Volumn 43, Issue 2, 2009, Pages 243-250

  Bal, Salih Haldun ^a   Heper, Yasemin ^a   Kumaş, Levent Tufan ^a   Mistik, Reşit ^a   Töre, Okan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Anti HBc; HBV DNA; Transfusion

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ARTICLE; BLOOD; BLOOD TRANSFUSION; DISEASE TRANSMISSION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; STANDARD;

BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS;

EID: 67649612533     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001; 41: 652-8.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-90.
3. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs positive cases of resolved hepatitis B infection. Transfusion 2001; 41: 329-32.
4. Yotsuyanagi H, Yasuda K, Moriya K, et al. Frequent presence of HBV in the sera of HBsAg negative, anti-HBc positive blood donors. Transfusion 2001; 41: 1093-9.
5. Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003; 43: 1442-8.
6. Drosten C, Weber M, Seifried E, Roth WK. Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening. Transfusion 2000; 40: 718-24.
7. Nalpas B, Berthelot P, Thiers V, et al. Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics. J Hepatology 1985; 1: 89-97.
8. Tanaka Y, Esumi M, Shikata T. Persistence of hepatitis B virus DNA after serological clearance of hepatitis B virus. Liver 1990; 10: 6-10.
9. Jongerius JM, Wester M, Cuypers HT, et al. New hepatitis B virus mutant form in a blood donor that is un-detectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38: 56-9.
10. Yenen OŞ,. Viral hepatitler, s: 641-700. Topçu AW, Söyletir G, Doǧanay M (ed), Infeksiyon Hastaliklan. 1996, Nobel Kitabevleri, Istanbul.
11. Kleinman SH, Kuhns MC, Todd DS, et al. Frequency of HBV-DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.
12. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002; 42: 869-75.
13. Allain JP. Genomic screening for blood-borne viruses in transfusion settings. Clin Lab Haematol 2000; 22: 1-10.
14. Tegtmeier G, Henderson S, McNamara A, Kuhns M. Contribution of anti-HBc screening to blood safety at regional blood centre in United States. Transfusion 1997; 37 (Suppl): 110.
15. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV-DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999; 107: 186-95.
16. Gerlich WH, Caspari G. Hepatitis viruses and the safety of blood donations. J Viral Hepat 1999; 6: 6-15.
17. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002; 42:1592-7.
18. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002; 117: 215-9.
19. Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight. Transfusion 2001; 41: 1081-5.
20. Allain JP. Occult hepatitis B infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
21. Durupmar B, Özbiber S, Günaydin M. Kan vericilerde hepatit B kor antikoru seropozitifliǧi ve önemi. Klimik Derg1993; 7:85-6.
22. Yayh G, Dündar V, Akgül A. Donor kanlannda anti-HBc antikorlannin araştinlmasinm önemi. Türk Mikrobi-yol Cem Derg 1994; 23: 91-4.
23. Badur Ş. Posttransfüzyon hepatitis sorunu. Türk Mikrobiyol Cem Derg 1991; 21: 234.
24. Howell DR, Webster MH, Barbara JA. Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or single HCV antibodies. Transfus Med 2000; 10: 265-9.
25. Iizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63:107-11.
26. Kojima M, Udo K, Takahashi Y, et al. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver. Gastroenterology 1977; 73: 664-7.
27. Marshall DA, Kleinman SH, Wong JB, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004; 86: 28-40.
28. Sato S, Ohhashi W, lhara H, Sakaya S, Kato T, Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001; 41: 1107-13.
29. Mistik R, Balik I. Türkiye'de viral hepatitlerin epidemiyolojik analizi, s: 10-55. Kiliçturgay K, Badur S (ed), Viral Hepatit 2001. 2001. Viral Hepatitle Savaşim Derneǧi Yayini, Istanbul.